Hims Wants to Keep Mailing You Copycat GLP-1s. It’s Getting Trickier.
Big Take15 Aug 2025

Hims Wants to Keep Mailing You Copycat GLP-1s. It’s Getting Trickier.

When a shortage of brand-name weight-loss drugs like Ozempic and Wegovy cleared the way for companies like Hims to fill the gap with cheaper, compounded versions, customers came flocking. But in February, the US Food and Drug Administration announced the shortage was over, leaving the company's strategy in flux and some investors worried.

On today’s Big Take podcast, host David Gura and Bloomberg healthcare reporter Madison Muller track how Hims became the king of copycat weight-loss drugs and what’s next for the company as it fights to hold onto the crown.

Read more: How Hims Became the King of Knockoff Weight-Loss Drugs

Cheap Ozempic Knockoffs Are Suddenly Everywhere. Are They Safe?

The Weight-Loss Drug Boom’s Prescription Problem

Listen and follow The Big Take on Apple Podcasts, Spotify or wherever you get your podcasts.

See omnystudio.com/listener for privacy information.

Avsnitt(819)

Weekend Listen: George Saunders Imagines an Oil Exec’s Deathbed

Weekend Listen: George Saunders Imagines an Oil Exec’s Deathbed

What is the best way to tell a climate story? This week on Zero, Akshat Rathi speaks with Booker Prize-winning novelist George Saunders. His new novel Vigil is an exploration of guilt, told on the dea...

8 Feb 43min

Betting on Sunday’s Game? Here’s Who You’re Up Against

Betting on Sunday’s Game? Here’s Who You’re Up Against

When the Seattle Seahawks take on the New England Patriots on Sunday, more than $2.6 billion in wagers will be on the line. A growing share — $800 million — will come through prediction markets like K...

6 Feb 18min

Generic Versions of Weight Loss Drugs Will Upend the Market

Generic Versions of Weight Loss Drugs Will Upend the Market

Shares of Novo Nordisk were down Thursday morning after Hims & Hers introduced a compounded version of its Wegovy pill. The dip came two days after Novo predicted its sales could drop as much as 13% t...

5 Feb 17min

Has the AI Reckoning Arrived?

Has the AI Reckoning Arrived?

AI anxiety is coursing through the stock market right now. From Tuesday’s global selloff in software and technology stocks to last week’s $381 billion Microsoft rout, investors are skittish over any s...

4 Feb 18min

Behind Thailand’s Push to Recriminalize Cannabis

Behind Thailand’s Push to Recriminalize Cannabis

Four years after Thailand became the first country in Asia to decriminalize cannabis, its booming market is at a crossroads. Initial high hopes for a tourism surge and a billion-dollar industry have b...

3 Feb 19min

What Is (And Isn’t) in the Latest Epstein Files Release

What Is (And Isn’t) in the Latest Epstein Files Release

The Department of Justice released another batch of documents from the so-called Epstein Files on Friday. It brings the total number of pages the DOJ has made public since December to nearly 3.5 milli...

2 Feb 18min

Weekend Listen: Why the Tech World Is Going Crazy for Claude Code

Weekend Listen: Why the Tech World Is Going Crazy for Claude Code

In the AI industry, there's always a hot new thing. First it was ChatGPT. Then it was the image generators. There was the DeepSeek moment. In the latter half of last year, everyone was excited about h...

1 Feb 54min

How Kevin Warsh Could Shape the Fed

How Kevin Warsh Could Shape the Fed

After months of speculation and a publicized selection process befitting The Apprentice, President Trump has announced his pick to lead the Federal Reserve: former Fed Governor Kevin Warsh. Historical...

30 Jan 18min

Populärt inom Politik & nyheter

motiv
aftonbladet-krim
rss-krimstad
p3-krim
fordomspodden
flashback-forever
rss-viva-fotboll
aftonbladet-daily
spar
svenska-fall
rss-sanning-konsekvens
rss-vad-fan-hande
rss-krimreportrarna
rss-frandfors-horna
grans
kungligt
dagens-eko
olyckan-inifran
krimmagasinet
svd-ledarredaktionen